Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enverdis was a German medical technology company focused on non-invasive cardiovascular functional diagnostics rather than a traditional therapeutic biotech pipeline. The company developed and marketed diagnostic systems intended to help detect heart and vascular disease, including products such as CARDIOLOGIC EXPLORER and VASCULAR EXPLORER. Its technology centered on electrode-based biosignal recording and computerized analysis for cardiac and vascular assessment in clinics and medical practices. Enverdis appears to have operated as a private medtech/diagnostics company founded in 1997, and its assets were acquired by Cardisio in January 2022. Following that asset acquisition, Enverdis does not appear to remain an active standalone operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enverdis.